Newsfiscal.ai
Bright Minds Biosciences' BMB-101 Phase 2 Trial Placed on FDA Partial Hold
· Published
Article summary
The U.S. Food and Drug Administration has placed a partial clinical hold on the Phase 2 trial of Bright Minds Biosciences' BMB-101 candidate.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…